2/4
03:25 pm
supn
Lupin Launches Topiramate Extended-Release Capsules in the United States [Yahoo! Finance]
Low
Report
Lupin Launches Topiramate Extended-Release Capsules in the United States [Yahoo! Finance]
1/31
07:46 am
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/31
01:33 am
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at
Wal
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at
Wal
1/26
04:18 am
supn
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds [Yahoo! Finance]
Low
Report
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds [Yahoo! Finance]
1/8
04:38 pm
supn
Is Supernus Pharmaceuticals (SUPN) Still Attractive After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Low
Report
Is Supernus Pharmaceuticals (SUPN) Still Attractive After Strong Multi-Year Share Price Gains [Yahoo! Finance]
1/1
12:22 pm
supn
3 Low-Volatility Stocks We're Skeptical Of [Yahoo! Finance]
Low
Report
3 Low-Volatility Stocks We're Skeptical Of [Yahoo! Finance]
12/19
10:09 am
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) had its price target raised by analysts at Stifel Nicolaus from $50.00 to $55.00. They now have a "hold" rating on the stock.
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) had its price target raised by analysts at Stifel Nicolaus from $50.00 to $55.00. They now have a "hold" rating on the stock.
12/19
07:06 am
supn
Strong Results Lifted Supernus Pharmaceuticals (SUPN) in Q3 [Yahoo! Finance]
Medium
Report
Strong Results Lifted Supernus Pharmaceuticals (SUPN) in Q3 [Yahoo! Finance]
12/16
12:23 am
supn
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back [Yahoo! Finance]
Low
Report
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back [Yahoo! Finance]
12/10
07:18 am
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/9
07:00 am
supn
Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada
Medium
Report
Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada
12/3
06:31 pm
supn
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference [Yahoo! Finance]
Low
Report
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference [Yahoo! Finance]
12/3
04:05 pm
supn
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Low
Report
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
11/26
02:19 pm
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
06:21 pm
supn
Assessing Supernus Pharmaceuticals After FDA Pipeline News and 24% Jump in 2025 [Yahoo! Finance]
Low
Report
Assessing Supernus Pharmaceuticals After FDA Pipeline News and 24% Jump in 2025 [Yahoo! Finance]
11/21
06:11 pm
supn
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/21
04:06 pm
supn
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/12
04:05 pm
supn
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
Low
Report
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
11/12
01:54 pm
supn
MERGE Wins Modern Healthcare x Ad Age Healthcare Marketing Impact Award: Agency of the Year [Yahoo! Finance]
Low
Report
MERGE Wins Modern Healthcare x Ad Age Healthcare Marketing Impact Award: Agency of the Year [Yahoo! Finance]
11/8
01:17 pm
supn
Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at
Wall
Low
Report
Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at
Wall